These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 21571007)

  • 1. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
    Thomas AM; Bui N; Graham D; Perkins JR; Yuva-Paylor LA; Paylor R
    Behav Brain Res; 2011 Oct; 223(2):310-21. PubMed ID: 21571007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.
    Thomas AM; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
    Psychopharmacology (Berl); 2012 Jan; 219(1):47-58. PubMed ID: 21656124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
    Yan QJ; Rammal M; Tranfaglia M; Bauchwitz RP
    Neuropharmacology; 2005 Dec; 49(7):1053-66. PubMed ID: 16054174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).
    Veeraragavan S; Graham D; Bui N; Yuva-Paylor LA; Wess J; Paylor R
    Behav Brain Res; 2012 Mar; 228(1):1-8. PubMed ID: 22123412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome.
    Veeraragavan S; Bui N; Perkins JR; Yuva-Paylor LA; Carpenter RL; Paylor R
    Psychopharmacology (Berl); 2011 Sep; 217(1):143-51. PubMed ID: 21487657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.
    Goebel-Goody SM; Wilson-Wallis ED; Royston S; Tagliatela SM; Naegele JR; Lombroso PJ
    Genes Brain Behav; 2012 Jul; 11(5):586-600. PubMed ID: 22405502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
    Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
    J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background.
    Ding Q; Sethna F; Wang H
    Behav Brain Res; 2014 Sep; 271():72-8. PubMed ID: 24886775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
    Zhang L; Alger BE
    J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.
    Osterweil EK; Krueger DD; Reinhold K; Bear MF
    J Neurosci; 2010 Nov; 30(46):15616-27. PubMed ID: 21084617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
    Vinueza Veloz MF; Buijsen RA; Willemsen R; Cupido A; Bosman LW; Koekkoek SK; Potters JW; Oostra BA; De Zeeuw CI
    Genes Brain Behav; 2012 Apr; 11(3):325-31. PubMed ID: 22257369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of fragile X syndrome in mice.
    Dölen G; Osterweil E; Rao BS; Smith GB; Auerbach BD; Chattarji S; Bear MF
    Neuron; 2007 Dec; 56(6):955-62. PubMed ID: 18093519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR.
    Price TJ; Rashid MH; Millecamps M; Sanoja R; Entrena JM; Cervero F
    J Neurosci; 2007 Dec; 27(51):13958-67. PubMed ID: 18094233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice.
    Aloisi E; Le Corf K; Dupuis J; Zhang P; Ginger M; Labrousse V; Spatuzza M; Georg Haberl M; Costa L; Shigemoto R; Tappe-Theodor A; Drago F; Vincenzo Piazza P; Mulle C; Groc L; Ciranna L; Catania MV; Frick A
    Nat Commun; 2017 Oct; 8(1):1103. PubMed ID: 29062097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.
    Ronesi JA; Collins KA; Hays SA; Tsai NP; Guo W; Birnbaum SG; Hu JH; Worley PF; Gibson JR; Huber KM
    Nat Neurosci; 2012 Jan; 15(3):431-40, S1. PubMed ID: 22267161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse.
    Higashimori H; Morel L; Huth J; Lindemann L; Dulla C; Taylor A; Freeman M; Yang Y
    Hum Mol Genet; 2013 May; 22(10):2041-54. PubMed ID: 23396537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
    Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
    Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audiogenic Seizures in the
    Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
    J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.